Active Ingredient: REGORAFENIB
Proprietary Name: STIVARGA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N203085
Product Number: 001
Approval Date: Sep 27, 2012
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information